Polycythemia Vera Drug Market Report

Global and Region Polycythemia Vera Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：217
  • REPORT CODE：GMM921535
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Polycythemia Vera Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Polycythemia Vera Drugmarket, defines the market attractiveness level of Polycythemia Vera Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Polycythemia Vera Drug industry, describes the types of Polycythemia Vera Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Polycythemia Vera Drug market and the development prospects and opportunities of Polycythemia Vera Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Polycythemia Vera Drug market in Chapter 13.

    By Player:

    • miRagen Therapeutics, Inc

    • Nerviano Medical Sciences Srl

    • ANP Technologies, Inc

    • PharmaEssentia Corporation

    • Novartis AG

    • F Hoffmann-La Roche Ltd

    • Karus Therapeutics Limited

    • Italfarmaco SpA

    • Bristol-Myers Squibb Company

    • Teva Pharmaceutical Industries Ltd

    • Gilead Sciences, Inc

    • Galena Biopharma, Inc

    By Type:

    • Dasatinib

    • Idelalisib

    • Givinostat

    • M-009

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Polycythemia Vera Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Polycythemia Vera Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Polycythemia Vera Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Polycythemia Vera Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Polycythemia Vera Drug Market Analysis and Outlook to 2022

    • 7.1 Global Polycythemia Vera Drug Consumption (2017-2022)

    • 7.2 United States Polycythemia Vera Drug Consumption (2017-2022)

    • 7.3 Europe Polycythemia Vera Drug Consumption (2017-2022)

    • 7.4 China Polycythemia Vera Drug Consumption (2017-2022)

    • 7.5 Japan Polycythemia Vera Drug Consumption (2017-2022)

    • 7.6 India Polycythemia Vera Drug Consumption (2017-2022)

    • 7.7 South Korea Polycythemia Vera Drug Consumption (2017-2022)

    8 Region and Country-wise Polycythemia Vera Drug Market Analysis and Outlook to 2028

    • 8.1 Global Polycythemia Vera Drug Consumption Forecast (2022-2028)

    • 8.2 United States Polycythemia Vera Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Polycythemia Vera Drug Consumption Forecast (2022-2028)

    • 8.4 China Polycythemia Vera Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Polycythemia Vera Drug Consumption Forecast (2022-2028)

    • 8.6 India Polycythemia Vera Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Polycythemia Vera Drug Consumption Forecast (2022-2028)

    9 Global Polycythemia Vera Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Polycythemia Vera Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Dasatinib Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Idelalisib Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Givinostat Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global M-009 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Polycythemia Vera Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Polycythemia Vera Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Polycythemia Vera Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Dasatinib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Idelalisib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Givinostat Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global M-009 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Polycythemia Vera Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Polycythemia Vera Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Polycythemia Vera Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Polycythemia Vera Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Polycythemia Vera Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Polycythemia Vera Drug Market Competitive Analysis

    • 14.1 miRagen Therapeutics, Inc

      • 14.1.1 miRagen Therapeutics, Inc Company Details

      • 14.1.2 miRagen Therapeutics, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 miRagen Therapeutics, Inc Polycythemia Vera Drug Product and Service

    • 14.2 Nerviano Medical Sciences Srl

      • 14.2.1 Nerviano Medical Sciences Srl Company Details

      • 14.2.2 Nerviano Medical Sciences Srl Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nerviano Medical Sciences Srl Polycythemia Vera Drug Product and Service

    • 14.3 ANP Technologies, Inc

      • 14.3.1 ANP Technologies, Inc Company Details

      • 14.3.2 ANP Technologies, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 ANP Technologies, Inc Polycythemia Vera Drug Product and Service

    • 14.4 PharmaEssentia Corporation

      • 14.4.1 PharmaEssentia Corporation Company Details

      • 14.4.2 PharmaEssentia Corporation Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 PharmaEssentia Corporation Polycythemia Vera Drug Product and Service

    • 14.5 Novartis AG

      • 14.5.1 Novartis AG Company Details

      • 14.5.2 Novartis AG Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis AG Polycythemia Vera Drug Product and Service

    • 14.6 F Hoffmann-La Roche Ltd

      • 14.6.1 F Hoffmann-La Roche Ltd Company Details

      • 14.6.2 F Hoffmann-La Roche Ltd Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 F Hoffmann-La Roche Ltd Polycythemia Vera Drug Product and Service

    • 14.7 Karus Therapeutics Limited

      • 14.7.1 Karus Therapeutics Limited Company Details

      • 14.7.2 Karus Therapeutics Limited Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Karus Therapeutics Limited Polycythemia Vera Drug Product and Service

    • 14.8 Italfarmaco SpA

      • 14.8.1 Italfarmaco SpA Company Details

      • 14.8.2 Italfarmaco SpA Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Italfarmaco SpA Polycythemia Vera Drug Product and Service

    • 14.9 Bristol-Myers Squibb Company

      • 14.9.1 Bristol-Myers Squibb Company Company Details

      • 14.9.2 Bristol-Myers Squibb Company Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol-Myers Squibb Company Polycythemia Vera Drug Product and Service

    • 14.10 Teva Pharmaceutical Industries Ltd

      • 14.10.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.10.2 Teva Pharmaceutical Industries Ltd Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Teva Pharmaceutical Industries Ltd Polycythemia Vera Drug Product and Service

    • 14.11 Gilead Sciences, Inc

      • 14.11.1 Gilead Sciences, Inc Company Details

      • 14.11.2 Gilead Sciences, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Gilead Sciences, Inc Polycythemia Vera Drug Product and Service

    • 14.12 Galena Biopharma, Inc

      • 14.12.1 Galena Biopharma, Inc Company Details

      • 14.12.2 Galena Biopharma, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Galena Biopharma, Inc Polycythemia Vera Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Polycythemia Vera Drug

    • Figure Polycythemia Vera Drug Picture

    • Table Global Polycythemia Vera Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Polycythemia Vera Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Polycythemia Vera Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Polycythemia Vera Drug Consumption by Country (2017-2022)

    • Figure United States Polycythemia Vera Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Polycythemia Vera Drug Consumption and Growth Rate (2017-2022)

    • Figure China Polycythemia Vera Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Polycythemia Vera Drug Consumption and Growth Rate (2017-2022)

    • Figure India Polycythemia Vera Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Polycythemia Vera Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Polycythemia Vera Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Polycythemia Vera Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Polycythemia Vera Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Polycythemia Vera Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Polycythemia Vera Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Polycythemia Vera Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Polycythemia Vera Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dasatinib Consumption and Growth Rate (2017-2022)

    • Figure Global Idelalisib Consumption and Growth Rate (2017-2022)

    • Figure Global Givinostat Consumption and Growth Rate (2017-2022)

    • Figure Global M-009 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Dasatinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Idelalisib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Givinostat Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global M-009 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Polycythemia Vera Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Polycythemia Vera Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table miRagen Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table miRagen Therapeutics, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table miRagen Therapeutics, Inc Polycythemia Vera Drug Product and Service

    • Table Nerviano Medical Sciences Srl (Foundation Year, Company Profile and etc.)

    • Table Nerviano Medical Sciences Srl Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nerviano Medical Sciences Srl Polycythemia Vera Drug Product and Service

    • Table ANP Technologies, Inc (Foundation Year, Company Profile and etc.)

    • Table ANP Technologies, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ANP Technologies, Inc Polycythemia Vera Drug Product and Service

    • Table PharmaEssentia Corporation (Foundation Year, Company Profile and etc.)

    • Table PharmaEssentia Corporation Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmaEssentia Corporation Polycythemia Vera Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Polycythemia Vera Drug Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Polycythemia Vera Drug Product and Service

    • Table Karus Therapeutics Limited (Foundation Year, Company Profile and etc.)

    • Table Karus Therapeutics Limited Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Karus Therapeutics Limited Polycythemia Vera Drug Product and Service

    • Table Italfarmaco SpA (Foundation Year, Company Profile and etc.)

    • Table Italfarmaco SpA Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Italfarmaco SpA Polycythemia Vera Drug Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Polycythemia Vera Drug Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Polycythemia Vera Drug Product and Service

    • Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences, Inc Polycythemia Vera Drug Product and Service

    • Table Galena Biopharma, Inc (Foundation Year, Company Profile and etc.)

    • Table Galena Biopharma, Inc Polycythemia Vera Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galena Biopharma, Inc Polycythemia Vera Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US